Healthcare investor: 'BioNTech was not fast enough'
Baillie Gifford partner Julia Angeles discusses investment perspectives on BioNTech, Moderna, weight loss markets, and upcoming AI-developed medicines.
Baillie Gifford partner Julia Angeles discusses investment perspectives on BioNTech, Moderna, weight loss markets, and upcoming AI-developed medicines.